Rebus Holdings Inc (RBSH)

[Mrragu]

With fingers crossed the promising scenario would be a IND filed and approved by the FDA in 2nd quarter. This would set up progress to clinical trials. The question is will they have the resources to take on trials? Will the approved IND generate investment in the stock (other than Sabby with their debentures)? Nirvana would be an outright sale of patents and drug IP for both RT-AR001and Mipsagargin to a pharma that has the resources to develop the platforms and take them forward. The loans (debentures) they get from Sabby keep the lights on but they would need millions to move forward with clinical trials. Bio is an expensive undertaking.